Cargando…

Does patient-tailored immunotherapy pave the way for new renal cell carcinoma treatment perspectives?

Detalles Bibliográficos
Autores principales: Van Brussel, Ilse, Van Craenenbroeck, Amaryllis H., Schrijvers, Dorien M., Cools, Nathalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708222/
https://www.ncbi.nlm.nih.gov/pubmed/26816729
http://dx.doi.org/10.3978/j.issn.2223-4683.2012.10.02
_version_ 1782409424093052928
author Van Brussel, Ilse
Van Craenenbroeck, Amaryllis H.
Schrijvers, Dorien M.
Cools, Nathalie
author_facet Van Brussel, Ilse
Van Craenenbroeck, Amaryllis H.
Schrijvers, Dorien M.
Cools, Nathalie
author_sort Van Brussel, Ilse
collection PubMed
description
format Online
Article
Text
id pubmed-4708222
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-47082222016-01-26 Does patient-tailored immunotherapy pave the way for new renal cell carcinoma treatment perspectives? Van Brussel, Ilse Van Craenenbroeck, Amaryllis H. Schrijvers, Dorien M. Cools, Nathalie Transl Androl Urol Editorial AME Publishing Company 2013-06 /pmc/articles/PMC4708222/ /pubmed/26816729 http://dx.doi.org/10.3978/j.issn.2223-4683.2012.10.02 Text en 2013 Translational Andrology and Urology. All rights reserved.
spellingShingle Editorial
Van Brussel, Ilse
Van Craenenbroeck, Amaryllis H.
Schrijvers, Dorien M.
Cools, Nathalie
Does patient-tailored immunotherapy pave the way for new renal cell carcinoma treatment perspectives?
title Does patient-tailored immunotherapy pave the way for new renal cell carcinoma treatment perspectives?
title_full Does patient-tailored immunotherapy pave the way for new renal cell carcinoma treatment perspectives?
title_fullStr Does patient-tailored immunotherapy pave the way for new renal cell carcinoma treatment perspectives?
title_full_unstemmed Does patient-tailored immunotherapy pave the way for new renal cell carcinoma treatment perspectives?
title_short Does patient-tailored immunotherapy pave the way for new renal cell carcinoma treatment perspectives?
title_sort does patient-tailored immunotherapy pave the way for new renal cell carcinoma treatment perspectives?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708222/
https://www.ncbi.nlm.nih.gov/pubmed/26816729
http://dx.doi.org/10.3978/j.issn.2223-4683.2012.10.02
work_keys_str_mv AT vanbrusselilse doespatienttailoredimmunotherapypavethewayfornewrenalcellcarcinomatreatmentperspectives
AT vancraenenbroeckamaryllish doespatienttailoredimmunotherapypavethewayfornewrenalcellcarcinomatreatmentperspectives
AT schrijversdorienm doespatienttailoredimmunotherapypavethewayfornewrenalcellcarcinomatreatmentperspectives
AT coolsnathalie doespatienttailoredimmunotherapypavethewayfornewrenalcellcarcinomatreatmentperspectives